Reporting Manager
Soleus Capital Master Fund, L.P.
Symbol
STAA
Shares outstanding
50,000,000 shares
Disclosed Ownership
500,000 shares
Ownership
1%
Form type
SCHEDULE 13G/A
Filing time
07 Nov 2025, 16:00:27 UTC
Date of event
30 Sep 2025
Previous filing
28 Mar 2025

Quoteable Key Fact

"Soleus Capital Master Fund, L.P. disclosed 1% ownership in STAAR SURGICAL COMPANY Common Stock, $0.01 par value per share (STAA) on 30 Sep 2025."

Quick Takeaways

  • Soleus Capital Master Fund, L.P. filed SCHEDULE 13G/A for STAAR SURGICAL COMPANY Common Stock, $0.01 par value per share (STAA).
  • Disclosed ownership: 1%.
  • Date of event: 30 Sep 2025.

What Changed

  • Previous schedule filing date: 28 Mar 2025.
  • Current filing was accepted on 07 Nov 2025, 16:00.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (6)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Soleus Capital Master Fund, L.P. 1% 500,000 0 500,000 /s/ Guy Levy Guy Levy/Managing Member
Soleus Capital, LLC 1% 500,000 0 500,000 /s/ Guy Levy Guy Levy/Managing Member
Soleus Capital Group, LLC 1% 500,000 0 500,000 /s/ Guy Levy Guy Levy/Managing Member
Soleus Capital Management, L.P. 1% 500,000 0 500,000 /s/ Guy Levy Guy Levy/Managing Member
Soleus GP, LLC 1% 500,000 0 500,000 /s/ Guy Levy Guy Levy/Managing Member
Guy Levy 1% 500,000 0 500,000 /s/ Guy Levy Guy Levy
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .